HIV-1 Env-specific memory and germinal center B cells in C57BL/6 mice

Viruses

Volumn 6, Issue 9, 2014, Pages 3400-3414

  Soldemo, Martina ^a   Pedersen, Gabriel K ^a   Karlsson Hedestam, Gunilla B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antibody; B cells; BALB c and C57BL 6 mice; Envelope glycoprotein; Germinal center; HIV 1; Immunization

Indexed keywords

ADJUVANT; ALUMINUM POTASSIUM SULFATE; CD38 ANTIGEN; CD45 ANTIGEN; CHLORHEXIDINE GLUCONATE; ENVELOPE PROTEIN; FAS ANTIGEN; GLYCOPROTEIN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYBRIDOMA; IMMUNOGENICITY; INOCULATION; KINETICS; MALE; MEMORY CELL; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS NEUTRALIZATION; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE MODEL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PHENOTYPE;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODY FORMATION; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GERMINAL CENTER; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHENOTYPE;

EID: 84907910326     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v6093400     Document Type: Article

References (42)

1. Zhang, L.; Kovalev, G.I.; Su, L. HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood 2007, 109, 2978-2981.
2. Sun, Z.; Denton, P.W.; Estes, J.D.; Othieno, F.A.; Wei, B.L.; Wege, A.K.; Melkus, M.W.; Padgett-Thomas, A.; Zupancic, M.; Haase, A.T.; et al. Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J. Exp. Med. 2007, 204, 705-714.
3. Baenziger, S.; Tussiwand, R.; Schlaepfer, E.; Mazzucchelli, L.; Heikenwalder, M.; Kurrer, M.O.; Behnke, S.; Frey, J.; Oxenius, A.; Joller, H.; et al. Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/-mice. Proc. Natl. Acad. Sci. USA 2006, 103, 15951-15956.
4. Akkina, R.; Berges, B.K.; Palmer, B.E.; Remling, L.; Neff, C.P.; Kuruvilla, J.; Connick, E.; Folkvord, J.; Gagliardi, K.; Kassu, A.; et al. Humanized Rag1-/-gammac-/-mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes. PLoS One 2011, 6, e20169.
5. Legrand, N.; Ploss, A.; Balling, R.; Becker, P.D.; Borsotti, C.; Brezillon, N.; Debarry, J.; de Jong, Y.; Deng, H.; Di Santo, J.P.; et al. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe 2009, 6, 5-9.
6. Li, M.; Gao, F.; Mascola, J.R.; Stamatatos, L.; Polonis, V.R.; Koutsoukos, M.; Voss, G.; Goepfert, P.; Gilbert, P.; Greene, K.M.; et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 2005, 79, 10108-10125.
7. Sundling, C.; Forsell, M.N.; O'Dell, S.; Feng, Y.; Chakrabarti, B.; Rao, S.S.; Lore, K.; Mascola, J.R.; Wyatt, R.T.; Douagi, I.; et al. Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates. J. Exp. Med. 2010, 207, 2003-2017.
8. Sundling, C.; Li, Y.; Huynh, N.; Poulsen, C.; Wilson, R.; O'Dell, S.; Feng, Y.; Mascola, J.R.; Wyatt, R.T.; Karlsson Hedestam, G.B. High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site. Sci. Transl. Med. 2012, 4, 142-96.
9. Sundling, C.; Martinez, P.; Soldemo, M.; Spangberg, M.; Bengtsson, K.L.; Stertman, L.; Forsell, M.N.; Karlsson Hedestam, G.B. Immunization of macaques with soluble HIV type 1 and influenza virus envelope glycoproteins results in a similarly rapid contraction of peripheral B-cell responses after boosting. J. Infect. Dis. 2013, 207, 426-431.
10. Sundling, C.; Phad, G.; Douagi, I.; Navis, M.; Karlsson Hedestam, G.B. Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells. J. Immunol. Meth. 2012, 386, 85-93.
11. Sundling, C.; Zhang, Z.; Phad, G.E.; Sheng, Z.; Wang, Y.; Mascola, J.R.; Li, Y.; Wyatt, R.T.; Shapiro, L.; Karlsson Hedestam, G.B. Single-Cell and Deep Sequencing of IgG-Switched Macaque B Cells Reveal a Diverse Ig Repertoire following Immunization. J. Immunol. 2014, 192, 3637-3644.
12. Lee, S.K.; Rigby, R.J.; Zotos, D.; Tsai, L.M.; Kawamoto, S.; Marshall, J.L.; Ramiscal, R.R.; Chan, T.D.; Gatto, D.; Brink, R.; et al. B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells. J. Exp. Med. 2011, 208, 1377-1388.
13. Paus, D.; Phan, T.G.; Chan, T.D.; Gardam, S.; Basten, A.; Brink, R. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J. Exp. Med. 2006, 203, 1081-1091.
14. Adams, C.L.; Macleod, M.K.; James Milner-White, E.; Aitken, R.; Garside, P.; Stott, D.I. Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation. Immunology 2003, 108, 274-287.
15. Zhang, Y.; Meyer-Hermann, M.; George, L.A.; Figge, M.T.; Khan, M.; Goodall, M.; Young, S.P.; Reynolds, A.; Falciani, F.; Waisman, A.; et al. Germinal center B cells govern their own fate via antibody feedback. J. Exp. Med. 2013, 210, 457-464.
16. Lu, Y.F.; Singh, M.; Cerny, J. Canonical germinal center B cells may not dominate the memory response to antigenic challenge. Int. Immunol. 2001, 13, 643-655.
17. Doyle-Cooper, C.; Hudson, K.E.; Cooper, A.B.; Ota, T.; Skog, P.; Dawson, P.E.; Zwick, M.B.; Schief, W.R.; Burton, D.R.; Nemazee, D. Immune tolerance negatively regulates B cells in knock- in mice expressing broadly neutralizing HIV antibody 4E10. J. Immunol. 2013, 191, 3186-3191.
18. Verkoczy, L.; Chen, Y.; Zhang, J.; Bouton-Verville, H.; Newman, A.; Lockwood, B.; Scearce, R.M.; Montefiori, D.C.; Dennison, S.M.; Xia, S.M.; et al.. Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses. J. Immunol. 2013, 191, 2538-2550.
19. Klein, F.; Diskin, R.; Scheid, J.F.; Gaebler, C.; Mouquet, H.; Georgiev, I.S.; Pancera, M.; Zhou, T.; Incesu, R.B.; Fu, B.Z.; et al.. Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell 2013, 153, 126-138.
20. Dosenovic, P.; Chakrabarti, B.; Soldemo, M.; Douagi, I.; Forsell, M.N.; Li, Y.; Phogat, A.; Paulie, S.; Hoxie, J.; Wyatt, R.T.; et al.. Selective expansion of HIV-1 envelope glycoprotein-specific B cell subsets recognizing distinct structural elements following immunization. J. Immunol. 2009, 183, 3373-3382.
21. Forsell, M.N.; Soldemo, M.; Dosenovic, P.; Wyatt, R.T.; Karlsson, M.C.; Karlsson Hedestam, G.B. Independent expansion of epitope-specific plasma cell responses upon HIV-1 envelope glycoprotein immunization. J. Immunol. 2013, 191, 44-51.
22. Yang, X.; Lee, J.; Mahony, E.M.; Kwong, P.D.; Wyatt, R.; Sodroski, J. Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin. J. Virol. 2002, 76, 4634-4642.
23. Flowjo, version vX.0.6; Tree Star, Inc.: Ashland, OR, USA, 2013.
24. Wu, L.; Oficjalska, K.; Lambert, M.; Fennell, B.J.; Darmanin-Sheehan, A.; Ni Shuilleabhain, D.; Autin, B.; Cummins, E.; Tchistiakova, L.; Bloom, L.; et al. Fundamental characteristics of the immunoglobulin VH repertoire of chickens in comparison with those of humans, mice, and camelids. J. Immunol. 2012, 188, 322-333.
25. Lee, E.C.; Liang, Q.; Ali, H.; Bayliss, L.; Beasley, A.; Bloomfield-Gerdes, T.; Bonoli, L.; Brown, R.; Campbell, J.; Carpenter, A.; et al.. Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery. Nat. Biotechnol. 2014, 32, 356-363.
26. Dosenovic, P.; Soldemo, M.; Scholz, J.L.; O'Dell, S.; Grasset, E.K.; Pelletier, N.; Karlsson, M.C.; Mascola, J.R.; Wyatt, R.T.; Cancro, M.P.; et al.. BLyS-mediated modulation of naive B cell subsets impacts HIV Env-induced antibody responses. J. Immunol. 2012, 188, 6018-6026.
27. Forsell, M.N.; Li, Y.; Sundback, M.; Svehla, K.; Liljestrom, P.; Mascola, J.R.; Wyatt, R.; Hedestam, G.B. Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by semliki forest virus. J. Virol. 2005, 79, 10902-10914.
28. Martin, R.M.; Brady, J.L.; Lew, A.M. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Meth. 1998, 212, 187-192.
29. Jouvin-Marche, E.; Morgado, M.G.; Leguern, C.; Voegtle, D.; Bonhomme, F.; Cazenave, P.A. The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes. Immunogenetics 1989, 29, 92-97.
30. Morgado, M.G.; Cam, P.; Gris-Liebe, C.; Cazenave, P.A.; Jouvin-Marche, E. Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. EMBO J. 1989, 8, 3245-3251.
31. Tiller, T.; Busse, C.E.; Wardemann, H. Cloning and expression of murine Ig genes from single B cells. J. Immunol. Meth. 2009, 350, 183-193.
32. Plotkin, S.A. Complex correlates of protection after vaccination. Clin. Infect. Dis. 2013, 56, 1458-1465.
33. Tran, K.; Poulsen, C.; Guenaga, J.; de Val, N.; Wilson, R.; Sundling, C.; Li, Y.; Stanfield, R.L.; Wilson, I.A.; Ward, A.B.; et al. Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign. Proc. Natl. Acad. Sci. USA 2014, 111, E738-E747.
34. Wolniak, K.L.; Noelle, R.J.; Waldschmidt, T.J. Characterization of (4-hydroxy-3-nitrophenyl)acetyl (NP)-specific germinal center B cells and antigen-binding B220- cells after primary NP challenge in mice. J. Immunol. 2006, 177, 2072-2079.
35. Rankin, A.L.; MacLeod, H.; Keegan, S.; Andreyeva, T.; Lowe, L.; Bloom, L.; Collins, M.; Nickerson-Nutter, C.; Young, D.; Guay, H. IL-21 receptor is critical for the development of memory B cell responses. J. Immunol. 2011, 186, 667-674.
36. McHeyzer-Williams, L.J.; Cool, M.; McHeyzer-Williams, M.G. Antigen-specific B cell memory: Expression and replenishment of a novel b220(-) memory b cell compartment. J. Exp. Med. 2000, 191, 1149-1166.
37. Liu, H.; Moynihan, K.D.; Zheng, Y.; Szeto, G.L.; Li, A.V.; Huang, B.; van Egeren, D.S.; Park, C.; Irvine, D.J. Irvine Structure-based programming of lymph-node targeting in molecular vaccines. Nature 2014, 507, 519-522.
38. Kanekiyo, M.; Wei, C.J.; Yassine, H.M.; McTamney, P.M.; Boyington, J.C.; Whittle, J.R.; Rao, S.S.; Kong, W.P.; Wang, L.; Nabel, G.J. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 2013, 499, 102-106.
39. Nie, X.; Basu, S.; Cerny, J. Immunization with immune complex alters the repertoire of antigen-reactive B cells in the germinal centers. Eur J. Immunol. 1997, 27, 3517-3525.
40. Isik, G.; van Montfort, T.; Boot, M.; Cobos Jimenez, V.; Kootstra, N.A.; Sanders, R.W. Chimeric HIV-1 envelope glycoproteins with potent intrinsic granulocyte-macrophage colony-stimulating factor (GM-CSF) activity. PLoS One 2013, 8, e60126.
41. Phogat, S.; Svehla, K.; Tang, M.; Spadaccini, A.; Muller, J.; Mascola, J.; Berkower, I.; Wyatt, R. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles. Virology 2008, 373, 72-84.
42. Koch, M.; Frazier, J.; Sodroski, J.; Wyatt, R. Characterization of antibody responses to purified HIV-1 gp120 glycoproteins fused with the molecular adjuvant C3d. Virology 2005, 340, 277-284.